Talazoparib for prostate cancer and breast cancer.
- Published in:
- Australian Prescriber, 2025, v. 48, n. 3, p. 111, doi. 10.18773/austprescr.2025.027
- Publication type:
- Article
Works matching IS 03128008 AND DT 2025 AND VI 48 AND IP 3
Results: 9
1
2
Spesolimab for generalised pustular psoriasis.
- Published in:
- Australian Prescriber, 2025, v. 48, n. 3, p. 109, doi. 10.18773/austprescr.2025.025
- Publication type:
- Article
3
Semaglutide for cardiovascular risk reduction in people who are overweight or have obesity without diabetes (new indication).
- Published in:
- Australian Prescriber, 2025, v. 48, n. 3, p. 107, doi. 10.18773/austprescr.2025.024
- Publication type:
- Article
4
More dual labelled medicines transition to sole names.
- Published in:
- Australian Prescriber, 2025, v. 48, n. 3, p. 106, doi. 10.18773/austprescr.2025.022
- Publication type:
- Article
5
Medicines used in the treatment of opioid dependence.
- Published in:
- Australian Prescriber, 2025, v. 48, n. 3, p. 98, doi. 10.18773/austprescr.2025.028
- By:
- Publication type:
- Article
6
Male and female pattern hair loss.
- Published in:
- Australian Prescriber, 2025, v. 48, n. 3, p. 93, doi. 10.18773/austprescr.2025.020
- By:
- Publication type:
- Article
7
Psoriasis: an update on topical and systemic therapies.
- Published in:
- Australian Prescriber, 2025, v. 48, n. 3, p. 87, doi. 10.18773/austprescr.2025.026
- By:
- Publication type:
- Article
8
Using pharmacogenomics to personalise drug therapy: which drugs, when and how.
- Published in:
- Australian Prescriber, 2025, v. 48, n. 3, p. 82, doi. 10.18773/austprescr.2025.021
- By:
- Publication type:
- Article
9
Update on long- and short-acting contraceptive methods.
- Published in:
- Australian Prescriber, 2025, v. 48, n. 3, p. 72, doi. 10.18773/austprescr.2025.023
- By:
- Publication type:
- Article